Biocryst Pharmaceuticals buy Needham & Company LLC
Start price
03.08.23
/
50%
€6.47
Target price
03.08.24
€10.96
Performance (%)
-1.24%
End price
04.08.24
€6.39
Summary
This prediction ended on 04.08.24 with a price of €6.39. With a performance of -1.24%, the BUY prediction for Biocryst Pharmaceuticals by Needham___Company_LL closed slightly in the red. Needham___Company_LL has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biocryst Pharmaceuticals | 3.781% | 3.781% | 9.660% |
iShares Core DAX® | 1.937% | 1.473% | 18.596% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% |
Comments by Needham___Company_LL for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock, down previously from $14.00.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Current prediction by Needham___Company_LL for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.70
06.11.23
06.11.23
€11.17
06.11.24
06.11.24
34.91%
22:26
22:26
Stopped prediction by Needham___Company_LL for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.98
07.05.24
07.05.24
€11.13
07.05.25
07.05.25
54.45%
22:26
22:26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.00
08.01.24
08.01.24
€10.95
08.01.25
08.01.25
28.17%
22:26
22:26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.67
20.04.23
20.04.23
€12.77
20.04.24
20.04.24
-38.50%
21.04.24
21.04.24